Oraverse (Septodont, Inc.)
Welcome to the PulseAid listing for the Oraverse drug offered from Septodont, Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Septodont, Inc. |
| NON-PROPRIETARY NAME: | Phentolamine Mesylate |
| SUBSTANCE NAME: | PHENTOLAMINE MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| ROUTE: | SUBMUCOSAL |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-06-01 |
| END MARKETING DATE: | 0000-00-00 |
Oraverse HUMAN PRESCRIPTION DRUG Details:
| Item Description | Oraverse from Septodont, Inc. |
| LABELER NAME: | Septodont, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.235(mg/mL) |
| START MARKETING DATE: | 2011-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0362-0101_fbc184a3-a9b7-447d-b100-fddcd2b07bf4 |
| PRODUCT NDC: | 0362-0101 |
| APPLICATION NUMBER: | NDA022159 |
Other PHENTOLAMINE MESYLATE Pharmaceutical Manufacturers / Labelers:
